Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 704 in total
| Status | Patent |
|---|---|
Application | Utility: TUNING OF RELEASE KINETICS IN HYDROGELS Filling date: 12 Sep 2025 Issue date: 6 Feb 2020 |
Grant | Utility: Antigen-binding proteins that antagonize leptin receptor Filling date: 12 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy Filling date: 12 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Methods and antibody compositions for tumor treatment Filling date: 12 Sep 2025 Issue date: 4 Feb 2020 |
Application | Utility: Treatment And Inhibition Of Inflammatory Lung Diseases In Patients Having Risk Alleles In The Genes Encoding IL33 And IL1RL1 Filling date: 12 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR Filling date: 12 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: Methods And Systems For Copy Number Variant Detection Filling date: 12 Sep 2025 Issue date: 30 Jan 2020 |
Grant | Utility: Humanized non-human animals with restricted immunoglobulin heavy chain loci Filling date: 12 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody Filling date: 12 Sep 2025 Issue date: 28 Jan 2020 |
Application | Utility: HUMANIZED IL-4 AND IL-4Ra ANIMALS Filling date: 12 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: MICE EXPRESSING A LIMITED IMMUNOGLOBULIN LIGHT CHAIN REPERTOIRE Filling date: 12 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof Filling date: 12 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof Filling date: 12 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS Filling date: 12 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: COMPOSITIONS AND METHODS OF MANUFACTURING PROTEIN MICROPARTICLES Filling date: 12 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION Filling date: 12 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: Human Antibodies to S. Aureus Hemolysin A Toxin Filling date: 12 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: HUMAN ANTIBODIES TO INFLUENZA HEMAGGLUTININ Filling date: 12 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: ANTI-IL36R ANTIBODIES Filling date: 12 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: NON-HUMAN ANIMAL MODELS OF DITRA DISEASE AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: Detection and Quantification of Glycosylated Peptides Filling date: 12 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: MODIFYING BINDING MOLECULES TO MINIMIZE PRE-EXISITING INTERACTIONS Filling date: 12 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: METHODS FOR MITIGATING DRUG TARGET INTERFERENCE IN AN ANTI-DRUG ANTIBODY (ADA) IMMUNOASSAY Filling date: 12 Sep 2025 Issue date: 16 Jan 2020 |
Grant | Utility: Conditional rodent Acvr1 mutant gene Filling date: 12 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4 antibody Filling date: 12 Sep 2025 Issue date: 14 Jan 2020 |
Application | Utility: METHODS OF TREATING SKIN CANCER BY ADMINISTERING A PD-1 INHIBITOR Filling date: 12 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND MUSCLE STRENGTH BY SPECIFICALLY ANTAGONIZING GDF8 AND OR ACTIVIN A Filling date: 12 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: HUMANIZED IL-6 AND IL-6 RECEPTOR Filling date: 12 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: ANTI-PD-1 ANTIBODIES FOR TREATMENT OF LUNG CANCER Filling date: 12 Sep 2025 Issue date: 9 Jan 2020 |
Grant | Utility: Angiopoietin-based interventions for treating cerebral malaria Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Humanized C3 animals Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Anti-activin A antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Amino acid acylation reagents and methods of using the same Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Predictive and prognostic biomarkers related to anti-angiogenic therapy of metastatic colorectal cancer Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Genetically modified mice that produce hybrid antibodies Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 |
Application | Utility: NOVEL CHO INTEGRATION SITES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION USING PAIRED GUIDE RNAS Filling date: 12 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION USING PAIRED GUIDE RNAS Filling date: 12 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: SYSTEMS AND METHODS FOR PREPARING A POLYPEPTIDE FROM A MIXTURE Filling date: 12 Sep 2025 Issue date: 2 Jan 2020 |
Grant | Utility: Nucleic acids encoding IL-33 antibodies Filling date: 12 Sep 2025 Issue date: 31 Dec 2019 |
Grant | Utility: Multimeric protein purity determination Filling date: 12 Sep 2025 Issue date: 31 Dec 2019 |
Grant | Utility: Anti-FGFR1c antibody-FGF21 fusion proteins Filling date: 12 Sep 2025 Issue date: 31 Dec 2019 |
Application | Utility: METHOD OF MANUFACTURING VEGF ANTAGONIST FUSION PROTEINS Filling date: 12 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: MULTIFUNCTIONAL ALLELES Filling date: 12 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: BISPECIFIC ANTI-PSMA X ANTI-CD28 ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: Methods for Treating Cancer with Bispecific Anti-CD3xMUC16 Antibodies and Anti-PD-1 Antibodies Filling date: 12 Sep 2025 Issue date: 26 Dec 2019 |
Grant | Utility: Anti-ASIC1 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 24 Dec 2019 |
Application | Utility: Fusion Polypeptides Capable Of Activating Receptors Filling date: 12 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR GENERATING OR MAINTAINING PLURIPOTENT CELLS Filling date: 12 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: NON-HUMAN ANIMALS CAPABLE OF ENGINEERED DH-DH REARRANGEMENT AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 19 Dec 2019 |
Showing 550 to 600 of 704 patents.